Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T

por Crees, Zachary D., Ghobadi, Armin
Publicado 2021

COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury

por Crees, Zachary D., Stockerl-Goldstein, Keith
Publicado 2022

Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide

por Crees, Zachary D., Rettig, Michael P., DiPersio, John F.
Publicado 2023

Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma

por So, Eiichiro, Crees, Zachary D., Crites, Danielle, Wang-Gillam, Andrea
Publicado 2017

hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang

por Mulnix, Richard E, Pitman, Ryan T, Retzer, Allison, Bertram, Ceyda, Arasi, Kavin, Crees, Zachary, Girard, Jennifer, Uppada, Srijayaprakash B, Stone, Amanda L, Puri, Neelu
Publicado 2013

Immune Adjuvant Therapy With Interleukin-7 in a Lymphopenic Patient With Aplastic Anemia and Mucormycosis

por Crees, Zachary D., Patel, Dilan A., Dram, Alexandra, Kim, Miriam, Bern, Michael D., Eberly, Allison R., Augustin, Kristan, Hotchkiss, Richard S., DiPersio, John F.
Publicado 2023

Targeting c-Met in melanoma: Mechanism of resistance and efficacy of novel combinatorial inhibitor therapy

por Etnyre, Deven, Stone, Amanda L, Fong, Jason T, Jacobs, Ryan J, Uppada, Srijayaprakash B, Botting, Gregory M, Rajanna, Supriya, Moravec, David N, Shambannagari, Manohar R, Crees, Zachary, Girard, Jennifer, Bertram, Ceyda, Puri, Neelu
Publicado 2014

EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer

por Crees, Zachary D, Shearrow, Caleb, Lin, Leo, Girard, Jennifer, Arasi, Kavin, Bhoraskar, Aayush, Berei, Joseph, Eckburg, Adam, Anderson, Austin D., Garcia, Christian, Munger, Ariana, Palani, Sunil, Smith, Thomas J, Sreenivassappa, Shylendra B, Vitali, Connie, David, Odile, Puri, Neelu
Publicado 2020

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor

por Crees, Zachary D., Rettig, Michael P., Bashey, Asad, Devine, Steven M., Jaglowski, Samantha, Wan, Fei, Zhou, Amy, Harding, Melinda, Vainstein-Haras, Abi, Sorani, Ella, Gliko-Kabir, Irit, Grossman, Brenda J., Westervelt, Peter, DiPersio, John F., Uy, Geoffrey L.
Publicado 2023

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial

por Crees, Zachary D., Rettig, Michael P., Jayasinghe, Reyka G., Stockerl-Goldstein, Keith, Larson, Sarah M., Arpad, Illes, Milone, Giulio A., Martino, Massimo, Stiff, Patrick, Sborov, Douglas, Pereira, Denise, Micallef, Ivana, Moreno-Jiménez, Gemma, Mikala, Gabor, Coronel, Maria Liz Paciello, Holtick, Udo, Hiemenz, John, Qazilbash, Muzaffar H., Hardy, Nancy, Latif, Tahir, García-Cadenas, Irene, Vainstein-Haras, Abi, Sorani, Ella, Gliko-Kabir, Irit, Goldstein, Inbal, Ickowicz, Debby, Shemesh-Darvish, Liron, Kadosh, Shaul, Gao, Feng, Schroeder, Mark A., Vij, Ravi, DiPersio, John F.
Publicado 2023